ANDREW CHARLES PAYNE,DUNCAN PHILIP MCHALE,MARINA CAVAZZANA,MARTIN JOHN ARMSTRONG,RODGER ANTHONY ALLEN,SVEN KRACKER
申请号：
BR112018072450
公开号：
BR112018072450A2
申请日:
2017.05.15
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
N -[(r)-1 -[8 -chloro -2 -(1 -oxypyridin -3 -yl)-quinolin -3 -yl]-2,2,2 -trifluoroethyl}-pyrimide [3,2 -d]pyrimidin -4 -ylamine is effective in the treatment and /or prevention of 3 -quinate Delta -activated (apds) phosphoinoshydride syndrome.n-{(r)-1-[8-cloro-2-(1-oxipiridin-3-il)-quinolin-3-il]-2,2,2-trifluoroetil}-pirido[3,2-d]pirimidin-4-ilamina é efetiva no tratamento e/ou prevenção da síndrome da fosfoinositídeo 3-quinase delta ativada (apds).
